Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. BAJAJHFL:I
9. CCHGY
10. PRY:IM

Go back to Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook

Teva Pharma (TEVA) Misses Q1 EPS by 15c, Revenue Beats, Offers Guidance

May 10, 2023 7:04 AM EDT

Teva Pharma (NYSE: TEVA) reported Q1 EPS of $0.40, $0.15 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $3.7 billion versus the consensus estimate of $3.61 billion.

GUIDANCE:

Teva Pharma sees FY2023 EPS of $2.25-$2.55, versus the consensus of... More